AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 281 min read$KNTK

ISQ Global Fund II GP LLC (Wahba Sadek, Bhandari Gautam) sold $4.2M of KNTK (indirect holdings)

ISQ Global Fund II GP LLC sold 76,260 indirectly-held shares of Kinetik Holdings Inc. (KNTK) at $55.28 ($4.22M total) on 2026-08-26. Filed jointly with I Squared Capital, LLC (10% owner), ISQ Holdings, LLC (10% owner), Wahba Sadek (10% owner) and Bhandari Gautam (10% owner).

Original reporting
SEC EDGAR · ISQ Global Fund II GP LLC, I Squared Capital, LLC, ISQ Holdings, LLC, Wahba Sadek, Bhandari Gautam
Published Aug 28, 2026, 11:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 28, 2026, 11:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$KNTK
Bearish
medium confidence
Mentioned
$KNTK
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KNTKBearishLow
01

Why it matters

The disclosed sale reduces insider stake from ~10% to slightly lower, providing fresh data for traders.

02

Market read

Primary disclosure of a material insider transaction for a small‑cap biotech, offering a new data point for short‑term trading decisions.

03

What to watch

No 10b5‑1 plan; sale appears discretionary, could be tax‑driven.

Relevance 6/10Novelty 7/10Timing: post‑market 2026‑08‑26

Background

SEC Form 4 filing by ISQ Global Fund II GP LLC reporting an insider sale.

Company-level read

Ticker impact

$KNTKBearishMedium confidence
Context

Form 4 disclosed a 76,260‑share sale at $55.28, total $4.2M, reducing insider ownership.

Expected impact

Possible modest dip in near‑term trading.

Evidence & confidence

Sale size is material for a small‑cap, but insider remains a 10% owner, limiting bearish impact.

Market effects

Sector

Minimal; reflects typical insider liquidity in biotech sector.

Regional

None; event is company‑specific.

Global

Low; limited to KNTK shareholders.

Counterpoint

What could challenge this read

Insider may be diversifying portfolio; sale does not imply negative fundamentals.

Key entities

  • company
    Kinetik Holdings Inc.

    Issuer of the securities sold.

  • insider
    ISQ Global Fund II GP LLC

    Reporting entity and 10% owner.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

KNTK insider trading history →

Related articles

SEP 9
$KNTKMedAI 8/10

Why is Kinetik Holdings stock surging today?

Kinetik Holdings' stock rose 5.2% in after-hours trading after Bloomberg reported the company is exploring strategic alternatives, including a potential sale. The company posted record Q2 2026 results with revenue up 36% YoY and net income more than doubled. Kinetik's management had raised its full-year 2026 guidance. U.S. equities broadly sold off during regular trading hours, with the S&P 500, Dow Jones, and Nasdaq all declining.

investing.com2 min
SEP 9
Med

Kinetik stock jumps 5% on potential sale exploration report

Kinetik Holdings Inc. (KNT) shares rose 5% in after-hours trading after reports it is exploring strategic options, including a potential sale. The company, backed by Blackstone Inc. (BX), has a market value of $8.9B. No final decision has been made. Kinetik closed regular trading at $54.55, down 0.8% but up 30% over the past year.

investing.com2 min